Enfortumab vedotin: targeting bladder cancer - 102017

Spotlight
Video

Enfortumab vedotin: targeting bladder cancer

VJOncology has 824 videos Subscribe Here

Loading........
Description: The American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, presented exciting updates in urothelial carcinoma. Here, Arlene Siefker-Radtke, MD, of the MD Anderson Cancer Center, Houston, TX, discusses data for the antibody-drug conjugate enfortumab vedotin, which targets Nectin-4 (EV-101; NCT02091999).
Shared By : VJOncology
Posted on : 08/21/18
Added : 9 months ago
Category : Bladder Cancer